Filing Details
- Accession Number:
- 0001069530-19-000072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-26 16:03:40
- Reporting Period:
- 2019-12-26
- Accepted Time:
- 2019-12-26 16:03:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069530 | Cassava Sciences Inc | SAVA | Pharmaceutical Preparations (2834) | 911911336 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1133806 | Remi Barbier | C/O Cassava Sciences, Inc. 7801 N. Capital Of Texas Hwy.; Suite 260 Austin TX 78731 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-26 | 10,000 | $4.15 | 968,855 | No | 4 | P | Indirect | Purchase by spouse of reporting person |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Purchase by spouse of reporting person |
Billionaire Hedge Funds
